• Sen. Marsha Blackburn and Tennessee Attorney General Jonathan Skrmetti are urging the Federal Trade Commission to investigate potentially dangerous, misleadingly advertised GLP-1 drugs.
• Counterfeit versions of these drugs, often sold online from foreign countries, may contain undisclosed or unsafe ingredients, including insulin.
• These fraudulent products pose a growing risk to consumers seeking legitimate weight loss and diabetes medications.
• Officials warn that some companies falsely claim FDA approval and advertise untested formulations, like nasal sprays for children.

Raising new concerns about potentially dangerous GLP-1 drugs marketed for weight loss, Sen. Marsha Blackburn, R-Tenn., sent a letter July 17 urging the Federal Trade Commission to investigate.

"These drugs, increasingly promoted as alternatives to FDA-approved medications like Ozempic and Wegovy, are being advertised in ways that mislead consumers and undermine both public health and integrity of the pharmaceutical marketplace," the senator and the letter's co-author, Tennessee Attorney General Jonathan Skrmetti wrote in the letter.

State leaders also pointed to a Feb. 20 warning issued by Skrmetti and attorneys general from 37 other states about potentially unsafe weight loss and diabetes drugs sold online and through social media. Fraudsters in foreign countries promise a quicker and easier way to get GLP-1 drugs but don't always disclose ingredients in counterfeit drugs. Some even contain unknown...

Read Full Story: https://news.google.com/rss/articles/CBMiqwFBVV95cUxPd1lCSDN4ZjlzcGNUYmNwQ09L...